Coya Therapeutics, Inc. (COYA) Tops Q3 EPS by 10c

Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q3 EPS of ($0.26), $0.10 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• JPMorgan Upgrades Nanya Technology Corp (2408:TT) to Overweight
• Crusoe in talks to raise $3B in funding - Bloomberg